A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain

Amino Acids

Volumn 38, Issue 3, 2010, Pages 691-700

  De Marco, Rosaria ^a   Di Gioia, Maria L ^a   Leggio, Antonella ^a   Liguori, Angelo ^a   Perri, Francesca ^a   Siciliano, Carlo ^a   Viscomi, Maria C ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Anticoagulants; Arginine bioisosteres; Ornithine; Sulfamoyl group; Thrombin inhibitors; Tripeptides

Indexed keywords

AMINO ACID DERIVATIVE; FIBRINOGEN; N ALPHA 9 FLUORENYLMETHOXYCARBONYL N DELTA SULFAMOYL TERT BUTOXYCARBONYL ORNITHINE METHYL ESTER; THROMBIN INHIBITOR; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; THROMBIN TIME;

ANTICOAGULANTS; ARGININE; DIPEPTIDES; DRUG DESIGN; HUMANS; HYDROGEN BONDING; OLIGOPEPTIDES; ORNITHINE; PARTIAL THROMBOPLASTIN TIME; SULFONAMIDES; THROMBIN; THROMBIN TIME;

EID: 77951666711     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0267-2     Document Type: Article

References (58)

1. RJ Austin T Xia J Ren TT Takahashi RW Roberts 2002 Designed arginine-rich RNA-binding peptides with picomolar affinity J Am Chem Soc 124 10966 10967 10.1021/ja026610b 10.1021/ja026610b (Pubitemid 35025642)
2. PB Balbo CN Patel KG Sell RS Adcock S Neelakantan PA Crooks MA Oliveira 2003 Spectrophotometric and steady-state kinetic analysis of the biosynthetic arginine decarboxylase of Yersinia pestis utilizing arginine analogues as inhibitors and alternative substrates Biochemistry 42 15189 15196 10.1021/bi0344127 10.1021/bi0344127 (Pubitemid 38031718)
3. A Bax DG Davis 1985 MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy J Magn Reson 65 355 360
4. W Bode D Turk A Kershikov 1992 The refined 1.9-A X-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships Protein Sci 1 426 471 (Pubitemid 23016868)
5. L Braunschweiler RR Ernst 1983 Coherence transfer by isotropic mixing-application to proton correlation spectroscopy J Magn Reson 53 521 528
6. J Das SD Kimball 1995 Thrombin active site inhibitors Bioorg Med Chem 3 999 1007 10.1016/0968-0896(95)00104-O 10.1016/0968-0896(95)00104-O
7. F De Tar De Los NP Luthra 1977 Conformations of proline J Am Chem Soc 99 1232 1244 10.1021/ja00446a040 10.1021/ja00446a040
8. A Derome M Williamson 1990 Rapid-pulsing artifacts in double-quantum-filtered COSY J Magn Reson 88 117 185
9. ML Di Gioia A Leggio A Le Pera A Liguori A Napoli C Siciliano G Sindona 2003 "One-pot" methylation of N-nosyl-α-amino acid methyl esters with diazomethane and their coupling to prepare N-methyl dipeptides J Org Chem 68 7416 7421 10.1021/jo034233v 10.1021/jo034233v (Pubitemid 37122493)
10. 3/N,N-dimethylaniline reagent system. Eur J Org Chem 4437-4441. doi: 10.1002/ejoc.200400321
11. ML Di Gioia A Leggio A Le Pera C Siciliano G Sindona A Liguori 2004 An efficient and highly selective deprotection of N-Fmoc-α-amino acid and lipophilic N-Fmoc-dipeptide methyl esters with aluminium trichloride and N,N-dimethylaniline J Pept Res 63 383 387 10.1111/j.1399-3011.2004.00104.x 10.1111/j.1399-3011.2004.00104.x 1:CAS:528:DC%2BD2cXktFGhsrk%3D 15102056 (Pubitemid 38639543)
12. JM Dougherty M Jiménez PR Hanson 2005 Synthesis of cyclic sulfamoyl carbamates and ureas via ring-closing metathesis Tetrahedron 61 6218 6230 10.1016/j.tet.2005.03.140 10.1016/j.tet.2005.03.140 1:CAS:528: DC%2BD2MXltFSgsbw%3D (Pubitemid 40812976)
13. MJ Fischer U Giese CS Harms MD Kinnick TD Lindstrom JR McCowan H-J Mest JM Morin Jr JT Mullaney M Paal A Rapp G Rühter KJ Ruterbories DJ Sall RM Scarborough T Schotten W Stenzel RD Towner SL Um BG Utterback VL Wyss JA Jakubowski 2000 Fused bicyclic Gly-Asp β-turn mimics with potent affinity for GPIIb-IIIa. Exploration of the arginine isostere Bioorg Med Chem Lett 10 385 389 10.1016/S0960-894X(00)00008-1 10.1016/S0960-894X(00)00008-1 (Pubitemid 30125196)
14. M Garrett T Tao WL Jolly 1964 The protonation and deprotonation of sulfamide and sulfamate in aqueous solutions J Phys Chem 68 824 826 10.1021/j100786a020 10.1021/j100786a020 1:CAS:528:DyaF2cXnt1Wqsw%3D%3D
15. M Groll T Nazif R Huber M Bogyo 2002 Probing structural determinants distal to the site of hydrolysis that control substrate specificity of the 20S proteasome Chem Biol 9 655 662 10.1016/S1074-5521(02)00144-8 10.1016/S1074-5521(02)00144-8 1:CAS:528:DC%2BD38XjvVWis70%3D 12031672 (Pubitemid 34593046)
16. M Groll M Götz M Kaiser E Weyher L Moroder 2006 TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome Chem Biol 13 607 614 10.1016/j.chembiol.2006.04.005 10.1016/j.chembiol.2006.04.005 1:CAS:528:DC%2BD28XlvFGqsLw%3D 16793518 (Pubitemid 43912453)
17. MK Hadden KS Orwig KP Kokko J Mazella TA Dix 2005 Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues Neuropharmacology 49 1149 1159 10.1016/j.neuropharm.2005.06.010 10.1016/j.neuropharm.2005.06.010 1:CAS:528:DC%2BD2MXht1ejs77I 16095636 (Pubitemid 41608639)
18. J Hauptmann J Stürzebecher 1999 Synthetic inhibitors of thrombin and factor Xa: from bench to bedside Thromb Res 93 203 241 10.1016/S0049-3848(98) 00192-3 10.1016/S0049-3848(98)00192-3 1:CAS:528:DyaK1MXhsFyrsbc%3D 10074907 (Pubitemid 29130456)
19. RCA Isaacs MG Solinsky KJ Cutrona CL Newton AM Naylor-Olsen JA Krueger SD Lewis BJ Lucas 2006 Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 1: weakly basic azoles Bioorg Med Chem Lett 16 338 342 10.1016/j.bmcl.2005.09.083 1:CAS:528:DC%2BD2MXht1GitLzN 16257203 (Pubitemid 41680623)
20. JA James MT McClain GDG Williams JB Harley 1999 Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies J Autoimmun 12 43 49 10.1006/jaut.1998.0252 10.1006/jaut.1998. 0252 1:STN:280:DyaK1M7ltl2itQ%3D%3D 10028021 (Pubitemid 29067667)
21. RTS Jim 1957 A study of the plasma thrombin time J Lab Clin Med 50 45 60 1:CAS:528:DyaG2sXpvFOgtw%3D%3D 13439266
22. HH Kim WS Lee JM Yang S Shin 2003 Basic peptide system for efficient delivery of foreign genes Biochim Biophys Acta 1640 129 136 10.1016/S0167- 4889(03)00028-4 10.1016/S0167-4889(03)00028-4 1:CAS:528:DC%2BD3sXjtlSksL0%3D 12729922 (Pubitemid 36555698)
23. JA Kloek KL Leschinsky 1976 An improved synthesis of sulfamoyl chlorides J Org Chem 41 4028 4029 10.1021/jo00887a022 10.1021/jo00887a022 1:CAS:528:DyaE2sXkvVym
24. KP Kokko CE Arrigoni TA Dix 2001 Selectivity enhancement induced by substitution of non-natural analogues of arginine and lysine in arginine-based thrombin inhibitors Bioorg Med Chem Lett 11 1947 1950 10.1016/S0960-894X(01) 00328-6 10.1016/S0960-894X(01)00328-6 1:CAS:528:DC%2BD3MXltFylsbw%3D 11459667 (Pubitemid 32675324)
25. AMP Koskinen J Helaja ETT Kumpulainen J Koivisto H Mansikkamäki K Rissanen 2005 Locked conformations for proline pyrrolidine ring: synthesis and conformational analysis of cis- and trans-4-tert-butylprolines J Org Chem 70 6447 6453 10.1021/jo050838a 10.1021/jo050838a 1:CAS:528:DC%2BD2MXlslaltb0%3D 16050708 (Pubitemid 41076529)
26. JM Langenhan JD Fisk SH Gellman 2001 Evaluation of hydrogen bonding complementarity between a secondary sulfonamide and an α-amino acid residue Org Lett 3 2559 2562 10.1021/ol016237x 10.1021/ol016237x 1:CAS:528:DC%2BD3MXltF2ktLk%3D 11483060 (Pubitemid 33627177)
27. K Lee W-H Jung M Kang S-H Lee 2000 Noncovalent thrombin inhibitors incorporating an imidazolylethynyl P1 Bioorg Med Chem Lett 10 2775 2778 10.1016/S0960-894X(00)00579-5 10.1016/S0960-894X(00)00579-5 1:CAS:528: DC%2BD3cXosFeltrY%3D 11133089
28. K Lee CW Park W-H Jung HD Park SH Lee KC Chung SK Park OH Kwon M Kang D-H Park SK Lee EE Kim SK Yoon A Kim 2003 Efficacious and orally bioavailable thrombin inhibitors based on a 2, 5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide J Med Chem 46 3612 3622 10.1021/jm030025j 10.1021/jm030025j 1:CAS:528: DC%2BD3sXltlCktL0%3D 12904065 (Pubitemid 36988648)
29. A Leggio 1997 Convenient and stereospecific homologation of N-fluorenylmethoxycarbonyl-α-amino acids to their β-homologues J Chem Soc Perkin Trans 1 1969 1971 10.1039/a700731k 10.1039/a700731k and references cited therein (Pubitemid 127785753)
30. Leggio A, Liguori A, Napoli A, Siciliano C, Sindona G (2000) New strategies for an efficient removal of the 9-fluorenylmethoxycarbonyl (Fmoc) protecting group in the peptide synthesis. Eur J Org Chem 573-575. doi: 10.1002/(SICI)1099-0690(200002)2000:4<573::AID-EJOC573>3.0.CO;2-I
31. BE Maryanoff 2004 Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G J Med Chem 47 769 787 10.1021/jm030493t 10.1021/jm030493t 1:CAS:528:DC%2BD2cXksFOgsQ%3D%3D 14761180 (Pubitemid 38176781)
32. H McDonald 2005 Overview of hemostasis and thrombosis; current status of antithrombotic therapies Thromb Res 117 15 17 10.1016/j.thromres.2005.05.007 10.1016/j.thromres.2005.05.007 (Pubitemid 41597023)
33. N Pellegrini M Schmitt S Guery J-J Bourguignon 2002 New strategies towards proline derivatives as conformationally constrained arginine analogues Tetrahedron Lett 43 3243 3246 10.1016/S0040-4039(02)00424-0 10.1016/S0040- 4039(02)00424-0 1:CAS:528:DC%2BD38XivVOkt7w%3D (Pubitemid 34310418)
34. 1-arginine mimetics Bioorg Med Chem Lett 13 3171 3176 10.1016/S0960-894X(03)00717-0 10.1016/S0960-894X(03)00717-0 12951087 (Pubitemid 37093822)
35. JC Powers JL Asgian ÖD Ekici KE James 2002 Irreversible inhibitors of serine, cysteine, and threonine proteases Chem Rev 102 4639 4750 10.1021/cr010182v 10.1021/cr010182v 1:CAS:528:DC%2BD38XosFSnsr4%3D 12475205
36. RB Proctor SI Rappaport 1961 The partial thromboplastin time with kaolin Am J Clin Pathol 36 212 219 1:STN:280:DyaF3c%2Flslyhsw%3D%3D 13738153
37. ML Quan CD Ellis MY He AY Lliauw PYS Lam KA Rossi RM Knabb JM Luettgen MR Wright PC Wong RR Wexler 2003 Nonbenzamidine isoxazoline derivatives as factor Xa inhibitors Bioorg Med Chem Lett 13 1023 1028 10.1016/S0960-894X(03)00080-5 10.1016/S0960-894X(03)00080-5 1:CAS:528:DC%2BD3sXitFGkt7s%3D 12643903 (Pubitemid 36331791)
38. JL Radkiewicz MA McAllister E Goldstein KN Houk 1998 A theoretical investigation of phosphonamidates and sulfonamides as protease transition state isosteres J Org Chem 63 1419 1428 10.1021/jo971425f 10.1021/jo971425f 1:CAS:528:DyaK1cXhsFOqsL8%3D (Pubitemid 28136908)
39. KVR Reddy RD Yedery C Aranha 2004 Antimicrobial peptides: premises and promises Int J Antimicrob Agents 24 536 547 10.1016/j.ijantimicag.2004.09.005 10.1016/j.ijantimicag.2004.09.005 1:CAS:528:DC%2BD2cXhtVSntbnI 15555874 (Pubitemid 39536106)
40. 1H NMR spectra of proteins via double quantum filtering Biochem Biophys Res Commun 117 479 485 10.1016/0006-291X(83)91225-1 10.1016/0006-291X(83)91225-1
41. NC Rockwell DJ Krysan T Komiyama RS Fuller 2002 Precursor processing by Kex2/furin proteases Chem Rev 102 4525 4548 10.1021/cr010168i 10.1021/cr010168i 1:CAS:528:DC%2BD38XosFCqt7g%3D 12475200
42. Romoff TT (2003) Racemization assays. In: Goodman M, Felix A, Moroder L, Toniolo C (eds) Houben-Weyl methods of organic chemistry. Synthesis of peptides and peptidomimetics, vol E22b. Thieme Verlag, Stuttgart, Germany, pp. 660-663; see also references cited herein
43. FR Salemme G Spurlino R Bone 1997 Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery Structure 5 319 324 10.1016/S0969-2126(97)00189-5 10.1016/S0969-2126(97)00189-5 1:CAS:528:DyaK2sXisVyqtro%3D 9083110 (Pubitemid 27169933)
44. W Schaal A Karlsson G Ahlsén J Lindberg HO Andersson HU Danielson B Classon T Unge B Samuelsson J Hultén A Hallberg A Karlén 2001 Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors J Med Chem 44 155 169 10.1021/jm001024j 10.1021/jm001024j 1:CAS:528:DC%2BD3cXovVWmsrw%3D 11170625 (Pubitemid 32096660)
45. Schmuck C, Geiger L (2005) Design and synthesis of a new class of arginine analogues with an improved anion binding site in the side chain. Chem Commun (Camb) 772-774. doi: 10.1039/b415543b (Pubitemid 40313307)
46. KA Schug W Lindner 2005 Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues Chem Rev 105 67 114 10.1021/cr040603j 10.1021/cr040603j 1:CAS:528:DC%2BD2cXhtVKktbjL 15720152 (Pubitemid 40195930)
47. BG Shearer S Lee KW Franzmann HAR White DCJ Sanders RJ Kiff EP Garvey ES Furfine 1997 Conformationally restricted arginine analogues as inhibitors of human nitric oxide synthase Bioorg Med Chem Lett 7 1763 1768 10.1016/S0960-894X(97)00309-0 10.1016/S0960-894X(97)00309-0 1:CAS:528: DyaK2sXks1yqu7c%3D (Pubitemid 27321500)
48. WJ Spillane FA McHugh PO Burke 1998 Elimination mechanisms in the anilinolysis of sulfamoyl chlorides in chloroform and acetonitrile J Chem Soc Perkin Trans 2 13 18 10.1039/a706410a
49. Y St-Denis S Lévesque B Bachand JJ Edmunds L Leblond P Préville M Tarazi PD Winocour MA Siddiqui 2002 Novel bicyclic lactam inhibitors of thrombin: highly potent and selective inhibitors Bioorg Med Chem Lett 12 1181 1184 10.1016/S0960-894X(02)00131-2 10.1016/S0960-894X(02)00131-2 1:CAS:528:DC%2BD38XisFWgtro%3D 11934583 (Pubitemid 34270558)
50. K Sugase M Horikawa M Sugiyama MJ Ishiguro 2004 Restriction of a peptide turn conformation and conformational analysis of guanidino group using arginine-proline fused amino acids: application to mini atrial natriuretic peptide on binding to the receptor J Med Chem 47 489 492 10.1021/jm030232j 10.1021/jm030232j 1:CAS:528:DC%2BD3sXps1GmtL4%3D 14711318 (Pubitemid 38057890)
51. M Sugawara K Tonan S-I Ikawa 2001 Effect of solvent on the cis-trans conformational equilibrium of a proline imide bond of short model peptides in solution Spectrochim Acta A Mol Biomol Spectrosc 57 1305 1316 10.1016/S1386-1425(00)00493-5 10.1016/S1386-1425(00)00493-5 1:STN:280: DC%2BD38%2FhsVOntA%3D%3D 11419473 (Pubitemid 32421555)
52. CT Supuran A Scozzafava F Briganti BW Clare 2000 Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1 J Med Chem 43 1793 1806 10.1021/jm9903693 10.1021/jm9903693 1:CAS:528: DC%2BD3cXisVKku7k%3D 10794696 (Pubitemid 30305012)
53. C Tapparelli R Metternich C Echardt M Zurini G Claeson MF Scully SR Stone 1993 In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor J Biol Chem 268 4734 4741 1:CAS:528:DyaK3sXlslertr8%3D 8444849 (Pubitemid 23081587)
54. C-H Tung R Weissleder 2003 Arginine containing peptides as delivery vectors Adv Drug Deliv Rev 55 281 294 10.1016/S0169-409X(02)00183-7 10.1016/S0169-409X(02)00183-7 1:CAS:528:DC%2BD3sXmsVGhsA%3D%3D 12564981 (Pubitemid 36135919)
55. JDA Tyndall T Nall DP Fairlie 2005 Proteases universally recognize beta strands in their active sites Chem Rev 105 973 1000 10.1021/cr040669e 10.1021/cr040669e 1:CAS:528:DC%2BD2MXhtlSqtLo%3D 15755082 (Pubitemid 40527381)
56. JI Weitz M Crowther 2002 Direct thrombin inhibitors Thromb Res 106 V275 V284 10.1016/S0049-3848(02)00093-2 10.1016/S0049-3848(02)00093-2 1:CAS:528:DC%2BD38XnsVWrtLY%3D 12356489 (Pubitemid 35279149)
57. J-Y Winum L Toupet V Barragan G DeWynter J-L Montero 2001 N-(tert-butoxycarbonyl)-N-[4-(dimethylazaniumylidene)-1,4-dihydropyridin-1- ylsulfonyl]azanide: a new sulfamoylating agent. Structure and reactivity toward amines Org Lett 3 2241 2243 10.1021/ol010155r 10.1021/ol010155r 1:CAS:528:DC%2BD3MXktFOmt7g%3D 11440589 (Pubitemid 33627138)
58. A Zega G Mlinšek T Šolmajer A Trampuš-Bakija M Stegnar U Urleb 2004 Thrombin inhibitors built on an azaphenylalanine scaffold Bioorg Med Chem Lett 14 1563 1567 10.1016/j.bmcl.2003.12.083 10.1016/j.bmcl.2003.12.083 1:CAS:528:DC%2BD2cXhvV2itbc%3D 15006404 (Pubitemid 38299451)